Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Intestine-specific Apical sodium-dependent BA transporter (ASBT) Inhibitors have been developed as potential therapeutics for cholestasis, type-2 diabetes and NASH
Opposing to FXR agonist treatment, Apical sodium-dependent BA transporter (ASBT) Inhibitors increase hepatic bile acid synthesis and decrease plasma cholesterol
I…